Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05233566 · ClinicalTrials.gov registry record · Phase 3
Ketamine for Postoperative Avoidance of Depressive Symptoms: The K-PASS Feasibility Trial
A Phase 3 study of Postoperative Depression, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- Phase 3
- Development phase
- 32
- Enrollment target
- 1
- Study location
NCT05233566 is a Phase 3 study of Postoperative Depression that has completed, run by Washington University School of Medicine. The registered enrollment target is 32 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05233566, a Phase 3 study of Postoperative Depression, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 32 participants
- Enrollment target
- 1
- Study location
Study Summary
This protocol describes a feasibility trial that will evaluate the feasibility of conducting a full-scale phase 3 trial testing the hypothesis that a postoperative sustained, low-dose ketamine infusion can prevent postoperative depressive symptoms when administered to a targeted population of neurosurgical patients with a history of depression.
Conditions Studied
Interventions
- DRUG Ketamine
- DRUG Normal saline
Study Locations (1)
Missouri
- Washington University School of Medicine - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2022-04-25 |
| Est. Completion | 2023-03-08 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05233566
The ClinicalTrials.gov registry entry for NCT05233566 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Postoperative Depression appearing as the primary indexed condition, and to 2 interventions - of which Ketamine is the first listed.
NCT05233566 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.
Frequently Asked Questions
What is clinical trial NCT05233566 about?
NCT05233566 is a clinical study titled "Ketamine for Postoperative Avoidance of Depressive Symptoms: The K-PASS Feasibility Trial". This protocol describes a feasibility trial that will evaluate the feasibility of conducting a full-scale phase 3 trial testing the hypothesis that a postoperative sustained, low-dose ketamine infusion can prevent postoperative depressive symptoms when administered to a targeted population of neuros...
What is the current status of trial NCT05233566?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 32 participants. The study started on 2022-04-25. Estimated completion is 2023-03-08.
What conditions does trial NCT05233566 study?
This clinical trial studies the following conditions: Postoperative Depression.
What interventions are being tested in trial NCT05233566?
The interventions under investigation include: Ketamine (DRUG), Normal saline (DRUG).
Who is sponsoring clinical trial NCT05233566?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05233566 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Postoperative Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.